Review
doi: 10.1111/j.1538-7836.2007.02742.x.
Epub 2007 Aug 22.
Targeted inhibition of coagulation: oral agents show promise in phase III trials
Affiliations
- PMID: 17764539
- DOI: 10.1111/j.1538-7836.2007.02742.x
Item in Clipboard
Review
Targeted inhibition of coagulation: oral agents show promise in phase III trials
J Thromb Haemost.
2007 Nov.
Free article
No abstract available
Comment on
-
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.J Thromb Haemost. 2007 Nov;5(11):2178-85. doi: 10.1111/j.1538-7836.2007.02748.x. J Thromb Haemost. 2007. PMID: 17764540 Clinical Trial.
Similar articles
-
The human pharmacology of thrombin inhibition.Coron Artery Dis. 1996 Dec;7(12):911-8. doi: 10.1097/00019501-199612000-00006. Coron Artery Dis. 1996. PMID: 9116934 Review.
-
Development of oral anticoagulants.Br J Clin Pharmacol. 2007 Sep;64(3):263-5. doi: 10.1111/j.1365-2125.2007.02898.x. Epub 2007 May 15. Br J Clin Pharmacol. 2007. PMID: 17506786 Free PMC article. No abstract available.
-
Oral and parenteral anticoagulants: new kids on the block.J Postgrad Med. 2012 Oct-Dec;58(4):275-85. doi: 10.4103/0022-3859.105448. J Postgrad Med. 2012. PMID: 23298923 Review.
-
Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21. Clin Cardiol. 2013. PMID: 23338902 Free PMC article. Review.
-
Bleeding time and oral anticoagulant therapy.Thromb Haemost. 1993 May 3;69(5):523-4. Thromb Haemost. 1993. PMID: 8357429 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
